Jinjun Wu

1.4k total citations
39 papers, 1.1k citations indexed

About

Jinjun Wu is a scholar working on Pharmacology, Molecular Biology and Pharmacology. According to data from OpenAlex, Jinjun Wu has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 16 papers in Molecular Biology and 12 papers in Pharmacology. Recurrent topics in Jinjun Wu's work include Plant-based Medicinal Research (11 papers), Berberine and alkaloids research (8 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Jinjun Wu is often cited by papers focused on Plant-based Medicinal Research (11 papers), Berberine and alkaloids research (8 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Jinjun Wu collaborates with scholars based in China, Macao and United States. Jinjun Wu's co-authors include Zhongqiu Liu, Yanmei Lou, Linlin Lu, Muyan Kong, Zhenzhen Guo, Guiyu Zhang, Yuanfeng Zhu, Fangyuan Li, Zhongqiu Liu and Leyan Li and has published in prestigious journals such as Oncogene, Scientific Reports and Free Radical Biology and Medicine.

In The Last Decade

Jinjun Wu

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinjun Wu China 19 513 353 190 190 142 39 1.1k
Yihang Shen China 4 741 1.4× 248 0.7× 199 1.0× 146 0.8× 102 0.7× 4 1.3k
Jianxia Wen China 21 514 1.0× 400 1.1× 160 0.8× 185 1.0× 141 1.0× 61 1.3k
Chun-Feng Zhang China 21 587 1.1× 315 0.9× 128 0.7× 149 0.8× 99 0.7× 39 1.1k
Zhongxiang Zhao China 23 634 1.2× 251 0.7× 170 0.9× 183 1.0× 90 0.6× 79 1.2k
Tilak Khanal South Korea 23 668 1.3× 343 1.0× 145 0.8× 110 0.6× 158 1.1× 38 1.4k
Qichao Hu China 16 412 0.8× 190 0.5× 141 0.7× 145 0.8× 106 0.7× 43 1.0k
Wan‐Jung Lu Taiwan 22 479 0.9× 206 0.6× 154 0.8× 219 1.2× 104 0.7× 54 1.2k
Runzhi Zhang China 7 586 1.1× 359 1.0× 176 0.9× 294 1.5× 57 0.4× 18 1.2k
Hong-Ling Tan China 22 570 1.1× 350 1.0× 109 0.6× 248 1.3× 109 0.8× 63 1.2k
Shi Sun United States 20 933 1.8× 297 0.8× 106 0.6× 134 0.7× 125 0.9× 25 1.2k

Countries citing papers authored by Jinjun Wu

Since Specialization
Citations

This map shows the geographic impact of Jinjun Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinjun Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinjun Wu more than expected).

Fields of papers citing papers by Jinjun Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinjun Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinjun Wu. The network helps show where Jinjun Wu may publish in the future.

Co-authorship network of co-authors of Jinjun Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jinjun Wu. A scholar is included among the top collaborators of Jinjun Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinjun Wu. Jinjun Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Yuting, Yinli Zheng, Haipeng Chen, et al.. (2025). Erianin triggers ferroptosis in colorectal cancer cells by facilitating the ubiquitination and degradation of GPX4. Phytomedicine. 139. 156465–156465. 8 indexed citations
2.
Zhang, Ying, et al.. (2024). Salvianolic Acid B Significantly Suppresses the Migration of Melanoma Cells via Direct Interaction with β-Actin. Molecules. 29(4). 906–906. 4 indexed citations
3.
Wu, Jinjun, Hongbin Li, Siyu Huang, et al.. (2024). Network pharmacology and experimental validation to explore the mechanism of Changji'an formula against irritable bowel syndrome with predominant diarrhea. Heliyon. 10(12). e33102–e33102. 1 indexed citations
4.
Yao, Jingjing, Zhenzhen Guo, Ming Ding, et al.. (2024). HBB contributes to individualized aconitine-induced cardiotoxicity in mice via interfering with ABHD5/AMPK/HDAC4 axis. Acta Pharmacologica Sinica. 45(6). 1224–1236. 5 indexed citations
5.
Zheng, Yinli, Leyan Li, Haipeng Chen, et al.. (2023). Luteolin exhibits synergistic therapeutic efficacy with erastin to induce ferroptosis in colon cancer cells through the HIC1-mediated inhibition of GPX4 expression. Free Radical Biology and Medicine. 208. 530–544. 36 indexed citations
6.
7.
8.
Wu, Jinjun, Muyan Kong, Yanmei Lou, et al.. (2021). Simultaneous Activation of Erk1/2 and Akt Signaling is Critical for Formononetin-Induced Promotion of Endothelial Function. Frontiers in Pharmacology. 11. 608518–608518. 18 indexed citations
9.
Lou, Yanmei, Muyan Kong, Leyan Li, et al.. (2021). Inhibition of the Keap1/Nrf2 Signaling Pathway Significantly Promotes the Progression of Type 1 Diabetes Mellitus. Oxidative Medicine and Cellular Longevity. 2021(1). 7866720–7866720. 18 indexed citations
10.
11.
Zheng, Yinli, Jinjun Wu, Ru Deng, et al.. (2021). G3BP2 regulated by the lncRNA LINC01554 facilitates esophageal squamous cell carcinoma metastasis through stabilizing HDGF transcript. Oncogene. 41(4). 515–526. 19 indexed citations
12.
Cui, Hui, Xinyi Lu, Ludi Zhang, et al.. (2020). (+/−)-Dievodialetins A−G: Seven pairs of enantiomeric coumarin dimers with anti-acetylcholinesterase activity from the roots of Evodia lepta Merr.. Phytochemistry. 182. 112597–112597. 12 indexed citations
13.
Lou, Yanmei, Zhenzhen Guo, Yuanfeng Zhu, et al.. (2019). Houttuynia cordata Thunb. and its bioactive compound 2-undecanone significantly suppress benzo(a)pyrene-induced lung tumorigenesis by activating the Nrf2-HO-1/NQO-1 signaling pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 242–242. 76 indexed citations
14.
Wu, Jinjun, Zhenzhen Guo, Yuanfeng Zhu, et al.. (2018). A systematic review of pharmacokinetic studies on herbal drug Fuzi : Implications for Fuzi as personalized medicine. Phytomedicine. 44. 187–203. 91 indexed citations
15.
Yu, Jia, Haihui Zheng, Jia‐Mei Chen, et al.. (2017). Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Regulate the Disposition of Acacetin Glucuronides. Pharmaceutical Research. 34(7). 1402–1415. 12 indexed citations
16.
Liu, Yuting, Yang Xia, Fangyuan Li, et al.. (2016). Novel histone deacetylase inhibitors derived from Magnolia officinalis significantly enhance TRAIL-induced apoptosis in non-small cell lung cancer. Pharmacological Research. 111. 113–125. 30 indexed citations
17.
Zhang, Guiyu, Fangyuan Li, Jinjun Wu, et al.. (2016). Regulation of drug-metabolizing enzymes and efflux transporters by Astragali radix decoction and its main bioactive compounds: Implication for clinical drug–drug interactions. Journal of Ethnopharmacology. 180. 104–113. 33 indexed citations
18.
Wu, Jinjun, Hong Chen, Guiyu Zhang, et al.. (2015). The significant inhibition on CYP3A caused by radix Aconiti single herb is not observed in the Wutou decoction: The necessity of combination therapy of radix Aconiti. Journal of Ethnopharmacology. 170. 251–254. 7 indexed citations
19.
Zhu, Lijun, Linlin Lu, Jinjun Wu, et al.. (2015). The Influences of Aconitine, an Active/Toxic Alkaloid from Aconitum, on the Oral Pharmacokinetics of CYP3A Probe Drug Buspirone in Rats. Drug Metabolism Letters. 8(2). 135–144. 6 indexed citations
20.
Wu, Jinjun, et al.. (2013). Development of a hydrophilic interaction chromatography-UPLC assay to determine trigonelline in rat plasma and its application in a pharmacokinetic study. Chinese Journal of Natural Medicines. 11(2). 164–170. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yihang Shen Breakdown of academic impact, for papers by Jianxia Wen Breakdown of academic impact, for papers by Chun-Feng Zhang Breakdown of academic impact, for papers by Zhongxiang Zhao Breakdown of academic impact, for papers by Tilak Khanal Breakdown of academic impact, for papers by Qichao Hu Breakdown of academic impact, for papers by Wan‐Jung Lu Breakdown of academic impact, for papers by Runzhi Zhang Breakdown of academic impact, for papers by Hong-Ling Tan Breakdown of academic impact, for papers by Shi Sun
Rankless by CCL
2026